Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM8 | O00222 | 14/20 | 0.69 |
| ▸ | GRM4 | Q14833 | 14/20 | 0.69 |
| ▸ | GRM6 | O15303 | 5/20 | 0.58 |
| ▸ | ACP3 | P15309 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13187563 | 0.86 | GRM8 (0.71) | GRM8GRM4GRM6ACP3L3MBTL1 | |
| SCHEMBL371435 | 0.81 | GRM8 (1.00) | GRM8GRM4GRM6 | |
| SCHEMBL10000476 | 0.74 | GRM8 (0.65) | GRM8GRM4GRM6ACP3CA12 | |
| SCHEMBL8238927 | 0.73 | GRM4 (1.00) | GRM8GRM4GRM6 | |
| SCHEMBL10000470 | 0.73 | GRM4 (1.00) | GRM8GRM4GRM6 | |
| SCHEMBL10000475 | 0.72 | GRM8 (0.71) | GRM8GRM4GRM6 | |
| SCHEMBL13187495 | 0.72 | GRM8 (0.53) | GRM8GRM4GRM6ACP3MEN1 | |
| SCHEMBL13187557 | 0.72 | GRM8 (0.60) | GRM8GRM4GRM6ACP3MEN1 | |
| SCHEMBL4703596 | 0.71 | TSHR (0.53) | GRM8GRM4GRM6ACP3MEN1 | |
| SCHEMBL27659937 | 0.71 | TSHR (0.57) | GRM8GRM4GRM6ACP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120016155-A1 | DIASTEREOISOMERS OF HYPOPHOSPHOROUS ACID DERIVATIVES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016155-A1 | DIASTEREOISOMERS OF HYPOPHOSPHOROUS ACID DERIVATIVES | PTH1R, P4HA1, FGF23 | GRM8 4160/4885GRM4 3644/4885GRM6 2596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.